GE Healthcare Partners With China’s BGI For Stem Cell Drug Discovery
This article was originally published in PharmAsia News
Executive Summary
The partners will examine the underlying genetic variation between ethnically diverse human stem cells, which can give scientists a more precise picture of the effect of a certain therapy compared to animal models.